ERBB2 and neoplasm: Ki67B values were different between HER2-negative and HER2-positive tumours (median 14·3% [IQR 8·2–24·6] in HER2-negative tumours, median 26·6% [17·0–37·4] in HER2-positive tumours; p<0·0001).